Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
INSULIN CONTAINING PHARMACEUTICAL COMPOSITIONS
Document Type and Number:
Japanese Patent JP2020105227
Kind Code:
A
Abstract:
To provide novel formulations of long acting insulin derivatives.SOLUTION: The invention relates to a pharmaceutical composition comprising an insulin derivative selected from the group consisting of: A14E, B16H, B25H, B29K((Nε-Eicosanedioyl-γGlu-[2-(2-{2-[2-(2-aminoethoxy)ethoxy]acetylamino}ethoxy)ethoxy]acetyl)), desB30 human insulin (Compound 1); A14E, B16H, B25H, B29K(Nε-Hexadecandioyl-γGlu), desB30 human insulin (Compound 2); A14E, B16H, B25H, B29K(Nε-Eicosanedioyl-γGlu), desB30 human insulin (Compound 3); and A14E, B25H, desB27, B29K(Nε-Octadecandioyl-γGlu), desB30 human insulin (Compound 4). The composition further comprises about 1 to about 2% (wt/wt) of glycerin; about 45 to about 75 mM of phenol; about 0 to about 19 mM of m-cresol; about 1.5 to about 2.5 moles of zinc ions per 6 moles of the insulin derivative; and about 75 mM or less of sodium chloride, and has a pH value in a range of about 7.2 to 8.0.SELECTED DRAWING: None

Inventors:
MATHIAS NORRMAN
SUSANNE HOSTRUP
DORTE BJERRE STEENSGAARD
HOLGER MARTIN STRAUSS
ROSA REBECCA ERRITZOE HANSEN
SVEND HAVELUND
MORTEN SCHLEIN
JESPER SONDERGAARD PEDERSEN
Application Number:
JP2020068954A
Publication Date:
July 09, 2020
Filing Date:
April 07, 2020
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
NOVO NORDISK AS
International Classes:
A61K38/28; A61K9/08; A61K38/26; A61K47/02; A61K47/10; A61P3/04; A61P3/06; A61P3/10; A61P43/00
Domestic Patent References:
JP6690062B22020-04-28
JP2002535287A2002-10-22
JP2013545782A2013-12-26
JP2011515358A2011-05-19
JP2015044875A2015-03-12
JP2016522241A2016-07-28
JP2011121963A2011-06-23
JP2010525033A2010-07-22
JP2015514120A2015-05-18
Attorney, Agent or Firm:
Yasuhiko Murayama
Shinya Mitsuhiro
Tatsuhiko Abe